201 related articles for article (PubMed ID: 25103648)
1. Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor).
Mulay K; White VA; Shah SJ; Honavar SG
Can J Ophthalmol; 2014 Aug; 49(4):326-32. PubMed ID: 25103648
[TBL] [Abstract][Full Text] [Related]
2. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
[TBL] [Abstract][Full Text] [Related]
3. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
Mittal R; Araujo I; Czanner G; Coupland SE
Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
[TBL] [Abstract][Full Text] [Related]
4. Sebaceous carcinoma: an immunohistochemical reappraisal.
Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of adipophilin immunostain in periocular carcinomas.
Milman T; Schear MJ; Eagle RC
Ophthalmology; 2014 Apr; 121(4):964-71. PubMed ID: 24290802
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
Jakobiec FA; Werdich X
Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
[TBL] [Abstract][Full Text] [Related]
7. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.
Asadi-Amoli F; Khoshnevis F; Haeri H; Jahanzad I; Pazira R; Shahsiah R
Am J Clin Pathol; 2010 Jul; 134(1):22-6. PubMed ID: 20551262
[TBL] [Abstract][Full Text] [Related]
8. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
[TBL] [Abstract][Full Text] [Related]
9. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
Jakobiec FA; Mendoza PR
Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.
Sinard JH
Arch Ophthalmol; 1999 Jun; 117(6):776-83. PubMed ID: 10369589
[TBL] [Abstract][Full Text] [Related]
11. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
Mulay K; Shah SJ; Aggarwal E; White VA; Honavar SG
Acta Ophthalmol; 2014 Dec; 92(8):e681-7. PubMed ID: 24930483
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining for adipophilin, perilipin and TIP47.
Muthusamy K; Halbert G; Roberts F
J Clin Pathol; 2006 Nov; 59(11):1166-70. PubMed ID: 16556662
[TBL] [Abstract][Full Text] [Related]
13. Sebaceous Carcinoma of the Eyelid.
Prieto-Granada C; Rodriguez-Waitkus P
Cancer Control; 2016 Apr; 23(2):126-32. PubMed ID: 27218789
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry in ocular carcinomas.
Sramek B; Lisle A; Loy T
J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
[TBL] [Abstract][Full Text] [Related]
15. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
16. Dimorphic immunohistochemical staining in ocular sebaceous neoplasms: a useful diagnostic aid.
Johnson JS; Lee JA; Cotton DW; Lee WR; Parsons MA
Eye (Lond); 1999; 13 ( Pt 1)():104-8. PubMed ID: 10396393
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation.
Bayer-Garner IB; Givens V; Smoller B
Am J Dermatopathol; 1999 Oct; 21(5):426-31. PubMed ID: 10535570
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
Ansai S; Arase S; Kawana S; Kimura T
J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
20. Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma.
Tope WD; Nowfar-Rad M; Kist DA
Dermatol Surg; 2000 May; 26(5):415-8. PubMed ID: 10816226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]